Pancreatic Cancer Research

ResearcherSheng Jing HospitalNo recent work listed

Xianghong Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7403-480X; OpenAlex author ID A5101946410. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper

Papers 9

  1. MicroRNA‑190b expression predicts a good prognosis and attenuates the malignant progression of pancreatic cancer by targeting MEF2C and TCF4. Last author DOI 10.3892/or.2021.8223↗
  2. m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling. Last author DOI 10.1016/j.omtn.2021.06.005↗
  3. Genetic alterations and functional networks of m6A RNA methylation regulators in pancreatic cancer based on data mining. Last author DOI 10.1186/s12967-021-03001-2↗
  4. MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12885-018-4526-z↗
  5. DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53‑deficient pancreatic cancer cells. Co-author DOI 10.3892/mmr.2017.7923↗
  6. HPCDb: an integrated database of pancreatic cancer Co-author DOI 10.1101/169771↗
  7. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.11001↗
  8. Sp1-driven up-regulation of miR-19a decreases RHOB and promotes pancreatic cancer. Last author DOI 10.18632/oncotarget.3975↗
  9. Antagonism of microRNA-99a promotes cell invasion and down-regulates E-cadherin expression in pancreatic cancer cells by regulating mammalian target of rapamyc… Last author DOI 10.1016/j.acthis.2013.12.013↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Juan Zeng · 5 shared papers, 2015–2022 · strength 0.63
  2. Yunwei Li · 3 shared papers, 2021–2022 · strength 0.52
  3. Heying Zhang · 4 shared papers, 2015–2021 · strength 0.43
  4. Yonggang Tan · 4 shared papers, 2015–2021 · strength 0.43
  5. Xiaofang Che · 3 shared papers, 2016–2018 · strength 0.22
  6. Xiujuan Qu · 3 shared papers, 2016–2018 · strength 0.22
  7. Ce Li · 2 shared papers, 2016–2018 · strength 0.12
  8. Huawei Zou · 2 shared papers, 2015–2017 · strength 0.11
  9. Na Song · 1 shared paper, 2018 · strength 0.09
  10. Wei Jing · 1 shared paper, 2018 · strength 0.09
  11. Yunpeng Liu · 1 shared paper, 2018 · strength 0.07
  12. Dan Li · 1 shared paper, 2017 · strength 0.07
  13. Dan Li · 1 shared paper, 2014 · strength 0.06
  14. Qian Dong · 1 shared paper, 2016 · strength 0.05
  15. Wei Cao · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.